158 related articles for article (PubMed ID: 1277211)
1. Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.
Draeger J; Peter G; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):355-9. PubMed ID: 1277211
[TBL] [Abstract][Full Text] [Related]
2. The problem of oncostatic specificity of cyclophosphamide (NSC-26271): Studies on reactions that control the alkylating and cytotoxic activity.
Hohorst HJ; Draeger U; Peter G; Voelcker G
Cancer Treat Rep; 1976 Apr; 60(4):309-15. PubMed ID: 1277206
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
Friedman OM; Wodinsky I; Myles A
Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
[TBL] [Abstract][Full Text] [Related]
4. Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.
Alarcon RA
Cancer Treat Rep; 1976 Apr; 60(4):327-35. PubMed ID: 1277208
[TBL] [Abstract][Full Text] [Related]
5. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
Peter G; Wagner T; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
[TBL] [Abstract][Full Text] [Related]
6. Identification and pharmacokinetics of cyclophosphamide (NSC-26271) metabolites in vivo.
Voelcker G; Wagner T; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):415-22. PubMed ID: 1277216
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and plain nitrogen mustard compounds.
Brock N
Cancer Treat Rep; 1976 Apr; 60(4):301-8. PubMed ID: 1277205
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative investigations of cyclophosphamide (NSC-26271), cyclophosphamide metabolites, and related compounds by field-desorption mass spectrometry.
Schulten HR
Cancer Treat Rep; 1976 Apr; 60(4):501-7. PubMed ID: 1277227
[TBL] [Abstract][Full Text] [Related]
9. Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
Cox PJ; Phillips BJ; Thomas P
Cancer Treat Rep; 1976 Apr; 60(4):321-6. PubMed ID: 179712
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cyclophosphamide (NSC-26271) metabolites and related derivatives by field-desorption and electron-impact mass spectrometry.
Przybylski M; Ringsdorf H; Voelcker G; Draeger U; Peter G; Hohorst HJ
Cancer Treat Rep; 1976 Apr; 60(4):509-16. PubMed ID: 1277228
[TBL] [Abstract][Full Text] [Related]
11. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
Benckhuysen C; van der Steen J; Spanjersberg EJ
Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
[TBL] [Abstract][Full Text] [Related]
12. [Intracavitary chemotherapy of S 180 ascites sarcoma in mice with 4-(S-ethanol)-sulfido-cyclophosphamide in combination with protector thiols].
Voelcker G; Jaschke A; Wrabetz E; Hohorst HJ
Arzneimittelforschung; 1984; 34(10):1291-8. PubMed ID: 6440565
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamic analysis of the reaction of phosphoramide mustard with protector thiols.
Seitz DE; Katterjohn CJ; Rinzel SM; Pearce HL
Cancer Res; 1989 Jul; 49(13):3525-8. PubMed ID: 2499418
[TBL] [Abstract][Full Text] [Related]
14. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetics of cyclophosphamide and cyclophosphamide metabolites in the mouse and their influence on the therapeutic effect of "activated" cyclophosphamide (4-hydroxycyclophosphamide) (author's transl)].
Voelcker G; Haeglsperger R
Arzneimittelforschung; 1982; 32(6):639-47. PubMed ID: 7202370
[TBL] [Abstract][Full Text] [Related]
16. The reaction of sulfhydryl groups with carbonyl compounds.
Włodek L
Acta Biochim Pol; 1988; 35(4):307-17. PubMed ID: 3247807
[TBL] [Abstract][Full Text] [Related]
17. X-ray crystallographic studies of cyclophosphamide (NSC-26271) derivatives.
Camerman A; Smith HW; Camerman N
Cancer Treat Rep; 1976 Apr; 60(4):517-22. PubMed ID: 1277229
[TBL] [Abstract][Full Text] [Related]
18. [S-Alkylmercapto groups for protection of the SH-function of cysteine. II. Thiol-disulfide exchange of asymmetric disulfides of cysteine].
Weber U; Hartter P; Flohé L
Hoppe Seylers Z Physiol Chem; 1970 Nov; 351(11):1389-94. PubMed ID: 5479830
[No Abstract] [Full Text] [Related]
19. Aspects of the teratology of cyclophosphamide (NSC-26271).
Ashby R; Davis L; Dewhurst BB; Espinal R; Penn RN; Upshall DG
Cancer Treat Rep; 1976 Apr; 60(4):477-82. PubMed ID: 1277224
[TBL] [Abstract][Full Text] [Related]
20. [Kinetics of the reaction of imidazole-SH-compounds with N-ethylmaleimide].
Schneider F; Wenck H
Hoppe Seylers Z Physiol Chem; 1969 Dec; 350(12):1521-30. PubMed ID: 5363654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
